Chinese genomics and molecular diagnostics firm NuProbe has secured $50 million in a Series B round of financing to move forward with its product and team expansion plans in China and the US.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
